Peptide–and protein–nanoparticle conjugates have emerged as powerful tools for
biomedical applications, enabling the treatment, diagnosis, and prevention of disease. In …

In recent years, various nanotechnology platforms in the area of medical biology, including
both diagnostics and therapy, have gained remarkable attention. Moreover, research and …

Over the last decade, significant progress has been made in the field of drug delivery. The
advent of engineered nanoparticles has allowed us to circumvent the initial limitations to …

The paradigm of using nanoparticulate pharmaceutical carriers has been well established
over the past decade, both in pharmaceutical research and in the clinical setting. Drug …

Drug toxicity is an important factor that contributes significantly to adverse drug events in
current healthcare practice. Application of lipid-based nanocarriers in drug formulation is …

Drug delivery systems can provide enhanced efficacy and/or reduced toxicity for anticancer
agents. Liposome drug delivery systems are able to modify the pharmacokinetics and …

Polymer micelles with cross-linked ionic cores were prepared by using block ionomer
complexes of poly (ethylene oxide)-b-poly (methacrylic acid)(PEO-b-PMA) copolymer and …

In recent years, nanoparticulate-mediated drug delivery research has examined a full
spectrum of nanoparticles that can be used in diagnostic and therapeutic cancer …

Background: Liposomes, phospholipids, nanosized bubbles with a bilayered membrane
structure, have drawn a lot of interest as pharmaceutical carriers for drugs and genes. In …

The use of nanotechnology has great potentials to revolutionize the future cancer diagnosis
and therapy. In this context, various nanoparticles (NPs) have been developed for targeted …